Member Info for beinthelead

A detailed video explainer. They’ve dragged out ‘full data’ release. I don’t think we ever see it.

Should have been sacked an age ago, alongside David Wilson. Both absolutely useless and stealing a living.

AVA6000 is not likely to see FDA approval anytime soon, at least before the current cash pot runs out. Which puts to bed the cold ones theory.

They need to partner. They need to licence. £30m every couple of years won’t cut it.

Mad.

She’s another wind up account PL.

Sounds really promising. That RNS was out of this world, so many Easter eggs re efficacy and dosing regimen. Can’t wait - £5 can’t come soon enough.

Exactly Ben. But don’t let truth get in the way of a good Derek-ism.

When the three amigos get so wound up, Mr W turns up with an article that hammers home their point, I.e. ‘we don’t know it works’.

Don’t tell them but it does.

Promoting ‘the cause’??

WTF is this - it’s not a charity! Jeez. Comic relief.

Paul Hill is bumbling. He has now clue other than to leech off Avcata’s popularity.

“ until you know how much more or less effective it is than standard Dox it'll be a bit of an educated guess”

But aren’t you saying that we need an enlarged trial to come to the above conclusion?

What are they though? How many more patients?

Please define: “ improved clinical outcomes”.

That might be a bonus.

He’s fuming.

Rest assured: The science works. Exactly as intended

The science works. Exactly as intended

That’s a mad lot of questions.

The science works. Exactly as intended.

Derek - Do you know anything about the efficacy of dox? Efficacy of the delivery mechanism is proven.

It’s fair to make the statement that the science and SP are disconnected. I’m not talking about wild ‘should be £20 now’ disconnect, more logical that the science costs money to progress. And delays really hurt the SP.

The science works and efficacy in terms of what Wyn refers to is utter rubbish. Doesn’t understand the first thing about the science.

Investing in this company should be all about the science. Trading stock in this company should be all about the SP inflections, ie CLN, funding, dilution etc.

I’ve asked myself that question. Very odd he pushes it so hard, always appears to be in the know. Always cc’s Myles in Twitter.

He’s a parasite.

Well said energy. Paul Hill is a disgrace - I hope beyond hope that he doesn’t speak to him again.

Exactly right. He’s chosen time and again to consult his 36 month calendar and still be late.

The technology however is performing tremendously. Look past AS and the investment becomes less lost. Somebody, at some point will buy it and AS won’t be able to do anything about it.

You’ve just told me more than I know, but wasn’t interested.

All I know is what you post. Your posting is inversely proportional to your SH it seems.

You’re worried. I can tell.